Massimo Volpe

Pubblicazioni

Titolo Pubblicato in Anno
Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Artificial intelligence in echocardiography. a better alternative to the human eye? EUROPEAN HEART JOURNAL 2023
SARS-CoV-2 Related Myocarditis. What We Know So Far JOURNAL OF CLINICAL MEDICINE 2023
Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2023
Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension MOLECULAR MEDICINE 2023
Effects of two-month treatment with a mixture of natural activators of autophagy on oxidative stress and arterial stiffness in patients with essential hypertension: A pilot study NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Telemedicine and Digital Medicine in the Clinical Management of Hypertension and Hypertension-Related Cardiovascular Diseases: A Position Paper of the Italian Society of Arterial Hypertension (SIIA) HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2023
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation CELLULAR AND MOLECULAR LIFE SCIENCES 2023
Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project EUROPEAN JOURNAL OF INTERNAL MEDICINE 2023
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2023
Hypertension, coronary artery disease and myocardial ischemic syndromes VASCULAR PHARMACOLOGY 2023
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2023
Abnormal expression of sphingolipid-metabolizing enzymes in the heart of spontaneously hypertensive rat models BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2023
More on aldosterone biosynthesis inhibition and resistant hypertension: a Phase-2 study with lorundrostat EUROPEAN HEART JOURNAL. ACUTE CARDIOVASCULAR CARE 2023
The Emerging Role of Prediabetes and Its Management: Focus on l-Arginine and a Survey in Clinical Practice HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2023
Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know REVIEWS IN CARDIOVASCULAR MEDICINE 2023
Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC) FRONTIERS IN CARDIOVASCULAR MEDICINE 2023
BNP/NT-proBNP levels are sensitive markers of impaired prognosis in patients without heart failure JACC. ADVANCES 2023
Reduction of high cholesterol levels by a preferably fixed-combination strategy as the first step in the treatment of hypertensive patients with hypercholesterolemia and high/very high cardiovascular risk: a consensus document by the Italian Society of Hypertension HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2022
Endothelial Dysfunction in Hypertension. Current Concepts and Clinical Implications FRONTIERS IN MEDICINE 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma